Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-16

FDA Approved: RUFINAMIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a generic version of Rufinamide for the treatment of seizures associated with Lennox-Gastaut syndrome, under Hikma Pharmaceuticals USA Inc.'s O…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)